These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 382919)

  • 21. [Effectiveness of the local use of komplamin and ATP in treating patients with primary and secondary optic atrophy].
    Shpak NI; Fedorova LI; Savko VV; Konovalova NV
    Oftalmol Zh; 1985; (3):159-62. PubMed ID: 4011098
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of complamine on various indicators of hemostasis and microcirculation in chronic ischemic heart disease].
    Bol'shakova RM; Dukhina MA; Furkalo NK; Solovtsova KM; Progonnaia VV
    Vrach Delo; 1978 Jan; (1):36-40. PubMed ID: 625941
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute effect of xanthinol nicotinate on the muscle clearance of 133Xenon.
    Szilvási I; Molnár G
    Ther Hung; 1973; 21(3-4):114-6. PubMed ID: 4806418
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of arthropathic psoriasis patients].
    Beliaev GM; Iushchenko LP
    Vestn Dermatol Venerol; 1984 Mar; (3):41-4. PubMed ID: 6730667
    [No Abstract]   [Full Text] [Related]  

  • 25. Xanthinol nicotinate in peripheral vascular disease.
    Davis E; Rozov H
    Practitioner; 1975 Dec; 215(1290):793-8. PubMed ID: 772653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Selected indicators of lipid metabolism in patients with chronic arteriosclerotic ischemia of the lower limbs].
    Maruszyński M; Bartnikowska E
    Wiad Lek; 1985 Jul; 38(14):1005-12. PubMed ID: 4072189
    [No Abstract]   [Full Text] [Related]  

  • 27. [Xanthinic derivatives in the treatment of intermittent claudication syndrome in diabetic patients].
    Gómez Reyes D; Rojas Hidalgo E
    Rev Clin Esp; 1986 Jul; 179(3):162. PubMed ID: 3764000
    [No Abstract]   [Full Text] [Related]  

  • 28. [The onset of circulatory venous gangrene of the arm and its successful treatment by thrombolysis].
    Neugodov IuV; Sokolov GF; Popov VV; El'skaia IE
    Vestn Khir Im I I Grek; 1989 Nov; 143(11):60. PubMed ID: 2633440
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of xanthinol nicotinate on the serum lipids and lipoproteins of patients with primary hyperlipoproteinemia Type IIb and IV].
    Haacke H; Parwaresch MR; Mäder C
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():829-32. PubMed ID: 1029294
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hepatic clearance of endogenous bilirubin following Sadamine(xanthinol niacinate) loading in brucellosis-induced hepatocellular damage and in chronic hepatitis].
    Juszczyk J; Kiczka W; Adamek J; Kryska A; Salwa W; Biczysko W; Zengteler G; Swietlicka-Grala J
    Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1303-5. PubMed ID: 1161569
    [No Abstract]   [Full Text] [Related]  

  • 31. Thermographical follow-up during treatment of chronic ulcerations with iontophoresis with xanthinol nicotinate.
    van der Kuy A; Aarts NJ
    Bibl Radiol; 1975; (6):203-9. PubMed ID: 1180851
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L; Landi A; Bársony J
    Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
    [No Abstract]   [Full Text] [Related]  

  • 33. [The observation of the influence of the unretarded form of xanthinol-niacinate (Complamine) in ulcus cruris venosum on the skin temperature of the lower extremities with the biochemical determination of the levels of the preparation (author's transl)].
    Resl V; Götzová ; Vitous J
    Cesk Dermatol; 1976 Dec; 51(6):389-93. PubMed ID: 1009598
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of a long-term study on the therapeutic effectiveness of xanthinol nicotinate in chronic hepatopathies].
    Dohrmann RE; Kessel ME
    Z Allgemeinmed; 1975 Sep; (26):1167-72. PubMed ID: 1226797
    [No Abstract]   [Full Text] [Related]  

  • 35. [The use of the descending genicular artery for long-term intra-arterial infusion in chronic ischemia of the extremities].
    Ivashchenko VV; Ezhelev VF
    Vestn Khir Im I I Grek; 1992; 149(11-12):326-30. PubMed ID: 8594790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experience with heparinoid sodium pentosan polysulfate (SP54) in the treatment of cerebral ischemia].
    Szirmai I; Fendler K; Kollár L; Romhányi M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):278-88. PubMed ID: 2427411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of teonikol and trental in the combined treatment of patients with suppurative surgical infection and concomitant diabetes mellitus].
    Nuzov BG
    Klin Med (Mosk); 1985 Dec; 63(12):73-8. PubMed ID: 4094394
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ergometric evaluation of treatment of ischemic heart disease with xavine].
    Zadionchenko VS; Vertkin AL; Martynov AI; Panchenkova LA; Troshina EV
    Sov Med; 1978 Jan; (1):68-73. PubMed ID: 635674
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of sudden deafness with increasing doses of sadamine].
    Betkowski A; Cyran-Rymarz A; Gośniak-Kurek E; Kuzniar W; Smolik B; Wysocka-Kuźniar S
    Wiad Lek; 1981 Jul; 34(14):1165-74. PubMed ID: 7331319
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic effect of complamine in atherosclerosis and ischemic heart disease].
    Kalmykova VI; Aronchuk EK
    Sov Med; 1976 Jan; (1):113-8. PubMed ID: 1273633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.